Antonino Carlo Privitera Selected Research

Therapeutics

12/2020	Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
1/2020	Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).
7/2008	Treatment strategies for chronic constipation: our experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonino Carlo Privitera Research Topics

Disease

8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022 - 05/2017
5	Crohn Disease (Crohn's Disease) 01/2022 - 01/2020
4	Ulcerative Colitis 01/2021 - 12/2018
2	COVID-19 04/2022 - 12/2020
1	Pneumonia (Pneumonitis) 04/2022
1	Spondylarthropathies 11/2020
1	Necrosis 01/2020
1	Hernia (Hernias) 01/2009
1	Rectocele 07/2008

Drug/Important Bio-Agent (IBA)

4	vedolizumabIBA 01/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 01/2020
3	Adalimumab (Humira)FDA Link 11/2021 - 12/2018
2	Biosimilar PharmaceuticalsIBA 11/2021 - 01/2021
2	Infliximab (Remicade)FDA Link 01/2021 - 05/2017
2	golimumab FDA Link 01/2020 - 12/2018
1	Immunomodulating AgentsIBA 04/2022
1	SteroidsIBA 04/2022
1	ABP 501IBA 11/2021
1	CT-P13IBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 11/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Polypropylenes (Polypropylene)IBA 01/2009
1	parietexIBA 01/2009

Therapy/Procedure

3	Therapeutics 12/2020 - 07/2008
1	Psychology Biofeedback (Biofeedback) 07/2008